Optovate Limited
USPTO PatentsView assignee record - 20 granted patents across 15 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G02B (Optical Elements, Systems OR Apparatus).
The verdict
According to USPTO PatentsView, Optovate ranks #14,835 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 15 technology areas.
- #14,835
- of 49,997 US assignees by volume
- Top 24%
- by Innovation Score (45.0/100)
- 25.3
- avg claims per patent
- +133%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R14835 · Foreign Corporation #14,835 · 20 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 20 grants
- MID-PACK #14,835/49,997
- PHOTO-FINISH Ocera Therapeutics
- CPC-FOCUS G02B · 15 areas
- INNOV-PAR 45.0/100
- CLAIMS-DENSE 25.3 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +133% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Ocera Therapeutics, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Optovate’s 45.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Optovate
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Optovate · this assignee
Optovate · this assignee
45 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Optovate's Innovation Score is 45.0/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Optovate?
Each dot is one of Optovate’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Optovate’s own 25.3 claims/patent is ABOVE the 12.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Optovate's grants concentrate
Optovate Limited is a focused PatentsView assignee: 15 CPC subclasses with 90% of grants classified under G02B (Optical Elements, Systems OR Apparatus). Peak complete grant year is 2020 (6 grants) versus a trough of 1 in 2017. By volume, Optovate sits between Ocera Therapeutics, Inc. and Owl biomedical, Inc..
Optovate's three-year grant acceleration
Optovate Limited shows 7 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Optovate's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Ocera Therapeutics
Ocera Therapeutics, Inc.
20 patents
- Olin
Olin Corporation
20 patents
- Omega (Omega )(Om…
Omega SA (Omega AG)(Omega Ltd.)
20 patents
- Oneida Air Systems
Oneida Air Systems, Inc.
20 patents
- Ostomycure AS
OstomyCure AS
20 patents
- Otonexus Medical
OtoNexus Medical Technologies, Inc.
20 patents
- Otsuka Medical De…
Otsuka Medical Devices Co., Ltd.
20 patents
- Owl biomedical
Owl biomedical, Inc.
20 patents
- Optovate ◀
Optovate Limited
20 patents
What this shows Optovate holds 20 patents at rank #14,832, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Optovate
By rank, the assignees closest to #14,832 in granted patent volume.
- Ocera Therapeutics, Inc. #14,828 · 20 patents
- Olin Corporation #14,829 · 20 patents
- Omega SA (Omega AG)(Omega Ltd.) #14,830 · 20 patents
- Oneida Air Systems, Inc. #14,831 · 20 patents
- OstomyCure AS #14,833 · 20 patents
- OtoNexus Medical Technologies, Inc. #14,834 · 20 patents
- Otsuka Medical Devices Co., Ltd. #14,835 · 20 patents
- Owl biomedical, Inc. #14,836 · 20 patents
Leaders in G02B (Optical Elements)
Other assignees with the most granted patents in Optovate's primary technology class.
- Samsung Electronics Co., Ltd. 4,608 in class
- Canon Kabushiki Kaisha 2,525 in class
- Fujifilm Corporation 2,173 in class
- BOE Technology Group Co., Ltd. 1,899 in class
- Olympus Corporation 1,893 in class
- Sony Group Corporation 1,572 in class
- Apple Inc. 1,367 in class
- Seiko Epson Corporation 1,332 in class
Optovate's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
45 Top 24% higher than 76% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 20.0% |
| 2017 | 1 | 5.0% |
| 2019 | 1 | 5.0% |
| 2020 | 6 | 30.0% |
| 2021 | 1 | 5.0% |
| 2022 | 2 | 10.0% |
| 2023 | 2 | 10.0% |
| 2024 | 3 | 15.0% |
Which technologies does Optovate Limited patent most?
Top 15 of 15 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Optovate Limited's patent record in context - here's where to go next.
- Optovate Limited's lead technology class is G02B (Optical Elements, Systems OR Apparatus), 90% of its portfolio - see every assignee active in that class. Explore G02B
- Ranked #14,835 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Optovate Limited against Ocera Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 45.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.